Tower Research Capital (TRC)’s OrthoPediatrics KIDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $35.7K | Buy |
1,864
+640
| +52% | +$11.1K | ﹤0.01% | 3031 |
|
|
2026
Q1 | $19.4K | Sell |
1,224
-1,076
| -47% | -$18.8K | ﹤0.01% | 3499 |
|
|
2025
Q4 | $40.8K | Buy |
2,300
+1,232
| +115% | +$21.6K | ﹤0.01% | 2582 |
|
|
2025
Q3 | $19.8K | Sell |
1,068
-600
| -36% | -$12.4K | ﹤0.01% | 3321 |
|
|
2025
Q2 | $35.8K | Buy |
1,668
+1,137
| +214% | +$24.6K | ﹤0.01% | 3257 |
|
|
2025
Q1 | $13.1K | Sell |
531
-1,322
| -71% | -$32.6K | ﹤0.01% | 3399 |
|
|
2024
Q4 | $43K | Buy |
1,853
+195
| +12% | +$4.88K | ﹤0.01% | 2649 |
|
|
2024
Q3 | $44.9K | Sell |
1,658
-2,216
| -57% | -$67.1K | ﹤0.01% | 2781 |
|
|
2024
Q2 | $111K | Buy |
3,874
+3,841
| +11,639% | +$118K | ﹤0.01% | 2505 |
|
|
2024
Q1 | $962 | Sell |
33
-4,408
| -99% | -$123K | ﹤0.01% | 5358 |
|
|
2023
Q4 | $144K | Buy |
4,441
+3,475
| +360% | +$101K | ﹤0.01% | 2351 |
|
|
2023
Q3 | $30.9K | Buy |
966
+165
| +21% | +$6.36K | ﹤0.01% | 2997 |
|
|
2023
Q2 | $35.1K | Buy |
801
+12
| +2% | +$553 | ﹤0.01% | 2884 |
|
|
2023
Q1 | $35K | Sell |
789
-100
| -11% | -$4.42K | ﹤0.01% | 2839 |
|
|
2022
Q4 | $35K | Sell |
889
-76
| -8% | -$3.17K | ﹤0.01% | 2611 |
|
|
2022
Q3 | $44K | Buy |
965
+68
| +8% | +$3.34K | ﹤0.01% | 3285 |
|
|
2022
Q2 | $39K | Buy |
897
+747
| +498% | +$34.2K | ﹤0.01% | 3120 |
|
|
2022
Q1 | $8K | Sell |
150
-96
| -39% | -$4.9K | ﹤0.01% | 4592 |
|
|
2021
Q4 | $15K | Sell |
246
-288
| -54% | -$17.9K | ﹤0.01% | 3996 |
|
|
2021
Q3 | $35K | Sell |
534
-397
| -43% | -$25.8K | ﹤0.01% | 3239 |
|
|
2021
Q2 | $59K | Buy |
931
+329
| +55% | +$18.9K | ﹤0.01% | 2890 |
|
|
2021
Q1 | $29K | Sell |
602
-8,839
| -94% | -$424K | ﹤0.01% | 3585 |
|
|
2020
Q4 | $389K | Sell |
9,441
-2,684
| -22% | -$123K | 0.01% | 1188 |
|
|
2020
Q3 | $557K | Buy |
12,125
+10,132
| +508% | +$470K | 0.01% | 1564 |
|
|
2020
Q2 | $87K | Buy |
+1,993
| New | +$89.6K | ﹤0.01% | 2588 |
|
|
2020
Q1 | – | Sell |
-154
| Closed | -$7K | – | 3493 |
|
|
2019
Q4 | $7K | Buy |
154
+34
| +28% | +$1.32K | ﹤0.01% | 2525 |
|
|
2019
Q3 | $4K | Buy |
+120
| New | +$4.16K | ﹤0.01% | 3422 |
|
|
2018
Q3 | – | Sell |
-140
| Closed | -$4K | – | 4015 |
|
|
2018
Q2 | $4K | Sell |
140
-3,052
| -96% | -$65.1K | ﹤0.01% | 3138 |
|
|
2018
Q1 | $48K | Sell |
3,192
-8,095
| -72% | -$143K | ﹤0.01% | 1698 |
|
|
2017
Q4 | $217K | Buy |
+11,287
| New | +$216K | 0.03% | 534 |
|
Other funds holding KIDS
Tower Research Capital (TRC)'s KIDS Position: Q2 2026 in Review
Tower Research Capital (TRC) increased its OrthoPediatrics (KIDS) stake by 52% in Q2 2026, buying an estimated $11.1K and bringing the position to 1,864 shares worth $35.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3031.
Tower Research Capital (TRC) first reported a position in KIDS in Q4 2017 and has held it in 30 quarters since. The position peaked at $557K in Q3 2020. 119 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.
- Tower Research Capital (TRC) held 1,864 shares of OrthoPediatrics worth $35.7K as of Q2 2026.
- Tower Research Capital (TRC) bought 640 OrthoPediatrics shares in Q2 2026, an estimated $11.1K.
- OrthoPediatrics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3031 holding.
- Tower Research Capital (TRC) first reported a position in OrthoPediatrics in Q4 2017 and has held it in 30 quarters since.
- Tower Research Capital (TRC)'s OrthoPediatrics position peaked at $557K in Q3 2020.
- 119 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.